Compugen (Israel)

Compugen (Israel)

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Compugen (Israel), Israel, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

54%


Total
Publications

164


Total Open
Publications

88


Total
Citations

13K


Open Access
Percentage

54%


Total
Publications

164


Total Open
Publications

88


Total
Citations

13K

Wikipedia

Website

download

Breakdown

14% 24% 16% 46%

Publisher Open

14%

Both

24%

Other Platform Open

16%

Closed

46%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

31%OA Journal

OA Journal 31%

19

Hybrid 34%

21

No Guarantees 35%

22

Other Platform Open

Domain 66%

43

Preprint 18%

12

Public 18%

12

Other Internet 17%

11

Institution 12%

8

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
43
Europe PMC
Domain
41
Figshare
Public
12
DOI
Other Internet
8
arXiv
Preprint
7
Semantic Scholar
Public
6
CiteSeer X
Other Internet
5
Zenodo
Public
3
bioRxiv
Preprint
3
University of Michigan - Deep Blue
Institution
2
1 / 4

Data updated 13 May 2024

Share

Share

Share